Subsequently, we treated HNSCC cells with the PPARγ inhibitor, GW9662 [21], and the western blot results showed that the expression of PPARγ was decreased (Fig. 6A). The gene discussed is PPARG; the disease is head and neck squamous cell carcinoma.